About Cleerly
Cleerly is a company based in Denver (United States) founded in 2016 by James Min.. Cleerly has raised $578.48 million across 5 funding rounds from investors including Fidelity Investments, Novartis and T. Rowe Price. Cleerly offers products and services including Cleerly Software, Cleerly Plaque Analysis, and Cleerly ISCHEMIA. Cleerly operates in a competitive market with competitors including HeartFlow, Perspectum, Qure.ai, IXICO and Zebra Medical Vision, among others.
- Headquarter Denver, United States
- Founders James Min
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cleerly, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$578.48 M (USD)
in 5 rounds
-
Latest Funding Round
$106 M (USD), Series C
Nov 19, 2024
-
Investors
Fidelity Investments
& 18 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cleerly
Cleerly offers a comprehensive portfolio of products and services, including Cleerly Software, Cleerly Plaque Analysis, and Cleerly ISCHEMIA. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI tool for analyzing CCTA scans to detect heart disease risks.
Software for assessing arterial plaque to inform treatment strategies.
AI system for identifying ischemia in cardiac imaging.
Unlock access to complete
Funding Insights of Cleerly
Cleerly has successfully raised a total of $578.48M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $106 million completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series C — $106.0M
-
First Round
First Round
(03 Apr 2020)
- Investors Count 19
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2024 | Amount | Series C - Cleerly | Valuation | Insight Partners | |
| Aug, 2022 | Amount | Series C - Cleerly | Valuation | T. Rowe Price , Fidelity Investments | |
| Mar, 2022 | Amount | Series C - Cleerly | Valuation | T. Rowe Price , Fidelity Investments |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cleerly
Cleerly has secured backing from 19 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Fidelity Investments, Novartis and T. Rowe Price. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment firm scaling software and technology companies from early to late stages.
|
Founded Year | Domain | Location | |
|
Investments in technology companies are conducted globally by Battery Ventures.
|
Founded Year | Domain | Location | |
|
Investment management services are provided focusing on healthcare innovation.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cleerly
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cleerly
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cleerly Comparisons
Competitors of Cleerly
Cleerly operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as HeartFlow, Perspectum, Qure.ai, IXICO and Zebra Medical Vision, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cardiovascular diagnostics are provided using CT scans and analytics.
|
|
| domain | founded_year | HQ Location |
Precision medicine software for liver disease diagnosis is offered.
|
|
| domain | founded_year | HQ Location |
AI-powered solutions for medical imaging diagnostics
|
|
| domain | founded_year | HQ Location |
AI-based medical image management and analysis solutions for healthcare organizations
|
|
| domain | founded_year | HQ Location |
Provider of AI and SaaS-based medical image based decision support tools
|
|
| domain | founded_year | HQ Location |
AI-augmented diagnostic tools for radiology imaging are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cleerly
Frequently Asked Questions about Cleerly
When was Cleerly founded?
Cleerly was founded in 2016 and raised its 1st funding round 4 years after it was founded.
Where is Cleerly located?
Cleerly is headquartered in Denver, United States. It is registered at Denver, Colorado, United States.
Who is the current CEO of Cleerly?
James Min is the current CEO of Cleerly. They have also founded this company.
Is Cleerly a funded company?
Cleerly is a funded company, having raised a total of $578.48M across 5 funding rounds to date. The company's 1st funding round was a Series C of $192M, raised on Apr 03, 2020.
What does Cleerly do?
Cleerly was founded in 2016 in Denver, United States, as an AI-based platform for cardiac health assessment. Coronary CT angiograms are analyzed to characterize and quantify atherosclerotic plaque in arteries. Diagnostic capabilities are provided to healthcare providers, enabling identification of risks and support for employee health outcomes. Personalized care options are facilitated within the healthcare sector.
Who are the top competitors of Cleerly?
Cleerly's top competitors include Perspectum, Qure.ai and Deeptek.
What products or services does Cleerly offer?
Cleerly offers Cleerly Software, Cleerly Plaque Analysis, and Cleerly ISCHEMIA.
Who are Cleerly's investors?
Cleerly has 19 investors. Key investors include Fidelity Investments, Novartis, T. Rowe Price, New Leaf Venture Partners, and Piper Sandler.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.